Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Fixed-Ratio Combination Treatment with Basal Insulin and GLP-1 Receptor Agonists

“New Developments in Type 2 Diabetes Management” is a new series dedicated to providing healthcare professionals with the latest education on novel fixed-ratio combination treatment options for patients with type 2 diabetes. Experts will cover the benefits of fixed-ratio combinations of basal insulin analogs and GLP-1 receptor agonists, individualized treatment plans, and current barriers to patient care. In addition, the faculty will demonstrate the proper administration of these new combination agents. Gain valuable insights to help your diabetic patients achieve optimal results all while receiving free CME/CNE credit. 

Episodes 0-0 of 0

    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.